Becker's Muscular Dystrophy (BMD) Terminated Phase 2 Trials for Ataluren (DB05016)

Also known as: Muscular Dystrophy, Becker / Becker's Muscular Dystrophy / Becker Muscular Dystrophy / Becker muscular dystrophy (disorder) / Obscure cardiomyopathy of Africa / Becker's muscular dystrophy (disorder) / (Becker's disease) or (obscure African cardiomyopathy)

IndicationStatusPhase
DBCOND0067711 (Becker's Muscular Dystrophy (BMD))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01009294Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)Treatment
NCT00847379Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)Treatment